ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 863,15
6,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Evogene Ltd (EVGN)

  7. Evogene Ltd (EVGN) Actualités

EVGN Evogene Ltd

0,71
0,0045 (0,64%)
Après les heures de négociation
Dernière mise à jour : 22:47:29
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Evogene Ltd EVGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0045 0,64% 0,71 22:47:29
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,70 0,6706 0,7315 0,71 0,7055
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202413:00PRNUSBiomica to Present at the American Society of Clinical..
11/4/202413:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
02/4/202413:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
28/3/202414:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
20/3/202414:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
19/3/202414:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
13/3/202414:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
07/3/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202413:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202413:00PRNUSAgPlenus Achieves Milestone in Collaboration with Corteva to..
05/3/202413:00PRNUSCasterra Announces New Agreements with Seed Producers in..
01/3/202413:03EDGAR2Form F-3 - Registration statement by foreign private issuers
28/2/202413:00PRNUSLavie Bio Successfully Secures Second Half Advance Payment..
26/2/202413:00PRNUSEvogene Schedules Fourth Quarter 2023 Financial Results..
22/2/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202413:00PRNUSAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as..
21/2/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202413:00PRNUSAgPlenus Announces Licensing & Collaboration Agreement with..
20/2/202413:00PRNUSSyngenta and Lavie Bio Announce Partnership to Discover and..
15/2/202402:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202413:08PRNUSEvogene and Verb Biotics Enter Collaboration Agreement to..
23/1/202413:00PRNUSBiomica CEO Set to Engage in Panel Discussion at 8th Annual..
17/1/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202413:00PRNUSBiomica Successfully Completes Phase I Trial Enrollment for..
09/1/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202313:00PRNUSBiomica CEO Set to Attend JP Morgan Healthcare Week in San..
19/12/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202313:00PRNUSCasterra Appoints New CEO and Expands Team to Drive Growth..
05/12/202313:00PRNUSLavie Bio Announces a Distribution Agreement with WinField..
28/11/202313:00PRNUSLavie Bio Announces Expansion of its Bio-Inoculant Product..
15/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202313:00PRNUSEvogene Reports Third Quarter 2023 Financial Results
08/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202312:00PRNUSEvogene Schedules Third Quarter 2023 Financial Results..
31/10/202312:00PRNUSColors Farm, Evogene and Ben-Gurion University Collaborate..
18/10/202313:00PRNUSEvogene Provides Operational Update Amidst Current Security..
27/9/202313:00PRNUSCasterra Delivers First Shipment of Castor Seeds to Africa
21/9/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202313:00PRNUSEvogene Reports Second Quarter 2023 Financial Results
15/8/202313:00PRNUSBiomica Opens Second Site to Advance Its Immuno-Oncology..
08/8/202313:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202313:00PRNUSEvogene Schedules Second Quarter 2023 Financial Results..
25/7/202313:00PRNUSEvogene's ChemPass AI Tech-Engine is Introduced with New..
19/7/202313:00PRNUSBiomica Announces Interim Positive Results from Pre-Clinical..
18/7/202320:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/7/202314:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Dernières Valeurs Consultées

NASDAQ
EVGN
Evogene
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés